|4Jan 2, 3:33 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Jan 2, 2014

Insider Transaction Report

Form 4
Period: 2013-02-22
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2013-02-22$16.85/sh347$5,84721,131 total

Documents

1 file
  • 4
    rrd398799.xmlPrimary